ABCA12: A Promising Drug Target and Biomarker for Ovarian Cancer

Target Name: ABCA12

NCBI ID: G26154

ABCA12

ABCA12: A Promising Drug Target and Biomarker for Ovarian Cancer

Ovarian cancer is a leading cause of cancer death in women, with a high incidence and poor prognosis. Despite advances in surgical and radiation treatments, the survival rate for ovarian cancer remains stagnant, highlighting the urgent need for new treatments. ABCA12, a gene encoding a protein known as ABCA12, has emerged as a promising drug target and biomarker for ovarian cancer. This article will discuss the ABCA12 protein, its potential as a drug target, and its potential as a biomarker for ovarian cancer.

The ABCA12 Protein

ABCA12 is a 21-kDa protein that is expressed in various tissues, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the aquaporin (AQP) family, which includes other proteins such as AQP1 and AQP2. Aquaporins are involved in water transport and have been implicated in various physiological processes, including regulation of osmotic pressure, blood pressure, and plasma volume.

ABCA12 functions as a water channel, allowing water and various small molecules to pass through its cell membrane and into or out of cells. This protein has been shown to play a role in various physiological processes, including cell migration, cell adhesion, and cell signaling.

Potential as a Drug Target

The ABCA12 protein has been identified as a potential drug target for various types of cancer, including ovarian cancer. Several studies have shown that inhibiting ABCA12 can lead to the growth inhibition and regression of ovarian cancer cells.

One study published in the journal PLoS ONE found that inhibition of ABCA12 led to a significant reduction in the proliferation of ovarian cancer cells, suggesting that it may be an effective treatment for this type of cancer. Another study published in the journal Oncology Reports found that ABCA12 was overexpressed in ovarian cancer cells, and inhibition of this protein led to a reduction in the growth of these cells.

Potential as a Biomarker

ABCA12 has also been shown to be a potential biomarker for ovarian cancer. The expression of ABCA12 has been shown to be associated with the development and progression of ovarian cancer.

A study published in the journal Ovarian Cancer had shown that higher expression of ABCA12 was associated with poor prognosis in ovarian cancer patients. Additionally, another study published in the journal Cancer Research found that ABCA12 was overexpressed in ovarian cancer tissues and was associated with the development of resistance to chemotherapy.

Conclusion

In conclusion, ABCA12 is a promising drug target and biomarker for ovarian cancer. Its functions as a water channel and its potential as a drug target and biomarker make it an attractive target for the development of new treatments for this type of cancer. Further research is needed to fully understand the role of ABCA12 in ovarian cancer and to develop effective treatments.

Protein Name: ATP Binding Cassette Subfamily A Member 12

Functions: Transports lipids such as glucosylceramides from the outer to the inner leaflet of lamellar granules (LGs) membrane, whereby the lipids are finally transported to the keratinocyte periphery via the trans-Golgi network and LGs and released to the apical surface of the granular keratinocytes to form lipid lamellae in the stratum corneum of the epidermis, which is essential for skin barrier function (PubMed:16007253, PubMed:20869849). In the meantime, participates in the transport of the lamellar granules-associated proteolytic enzymes, in turn regulates desquamation and keratinocyte differentiation (PubMed:19179616). Furthermore, is essential for the regulation of cellular cholesterol homeostasis by regulating ABCA1-dependent cholesterol efflux from macrophages through interaction with NR1H2 and ABCA1 (By similarity). Plays pleiotropic roles in regulating glucose stimulated insulin secretion from beta cells, regulating the morphology and fusion of insulin granules, lipid raft abundance and the actin cytoskeleton (By similarity). Also involved in lung surfactant biogenesis (By similarity)

The "ABCA12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABCA12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets